Zhaoke Ophthalmology-B (06622) has released its interim results for the 2026 fiscal year, showing total revenue of RMB 18.828 million, a year-on-year increase of 19.14%. However, the company recorded a net loss of approximately RMB 123 million, which represents a 5.12% rise compared to the prior corresponding period, translating to a loss per share of RMB 0.22.

The uptick in losses was primarily attributed to a decline in interest income from bank deposits, reflecting the downward trend in global interest rates since mid-2025. Additionally, the company recognized higher share-based payment expenses within its general and administrative costs during the period, further impacting the bottom line.